Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure

2010123 citationsJournal Article

Authors

Julio Núñez · Hospital Clínico Universitario de Valencia

Juan Sanchís · Hospital Clínico Universitario de Valencia

Vicent Bodı́ · Universitat de València

Gregg C. Fonarow · University of California, Los Angeles

Eduardo Núñez · Universitat de València

Vicente Bertomeu‐González · Hospital Universitari Sant Joan D'Alacant

Gema Miñana

Abstract

In patients admitted with AHF, CA125 added prognostic value beyond the information provided by BNP, and thus, their combination enables better 6-month risk stratification.

Topics & Keywords

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Potassium and Related Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 31, Issue 14, pp. 1752-1763

DOI: 10.1093/eurheartj/ehq142

Field-Weighted Citation Impact: 5.33